This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Robert's Most Recent Article

Are Fund Managers Better Than Their Funds?

04/20/09 - 04:51 PM EDT

For investors still cringing at their IRAs, 401(k)s or taxable mutual funds and exchange-traded funds, are you ready to take a chance on the companies that have brought you so many unhappy returns?

read more >

Other Articles by Robert

Free Reports

After Exubera, Uncertainty Reigns

10/22/07 - 04:01 PM EDT

Pfizer's decision to drop inhaled insulin could dim the prospects for competing products.

read more >
Hot Art From the Arctic

10/19/07 - 09:47 AM EDT

Inuit prints from northern Canada offer a beautiful -- and affordable -- investment.

read more >
Can Good Health Last for Medical IPOs?

09/11/07 - 02:20 PM EDT

The first part of the year was solid for new biotechs and health stocks.

read more >
Challenges Persist for Glaxo

08/22/07 - 04:43 PM EDT

Fans say the company is too big to fail, but it's also too big to grow much without developing more hits.

read more >
J&J's Risperdal Gets New Uses

08/22/07 - 04:35 PM EDT

The drug is approved by the FDA for younger patients.

read more >
Pfizer Finds New CFO

08/22/07 - 11:18 AM EDT

Frank D'Amelio will join the company from Alcatel-Lucent.

read more >
FDA Approves Novartis Osteoporosis Drug

08/20/07 - 05:19 PM EDT

Reclast is a once-a-year treatment.

read more >
Glaxo Drug Gets Black Box

08/14/07 - 05:38 PM EDT

Avandia will carry a new warning.

read more >
Wyeth Whacked on Drug Setbacks

08/10/07 - 01:49 PM EDT

It gets bad news from the FDA and pulls a hepatitis C drug candidate.

read more >
One Giant Leap for MannKind

08/09/07 - 05:48 PM EDT

The company will sell $350 million in debt, warrants and stock.

read more >
Page 3 of 147
Top Rated Stocks Top Rated Funds Top Rated ETFs